Model organism Study Guide

📖 Core Concepts Model organism – a non‑human species studied intensively so that results can be extrapolated to other organisms, especially humans. Evolutionary conservation – shared ancestry gives organisms common metabolic pathways, developmental mechanisms, and genes, making findings transferable. Disease‑model categories Homologous: same cause, symptoms, and treatment as the human disease. Isomorphic: same symptoms & treatment, but a different cause. Predictive: only a few disease aspects are reproduced; useful for probing mechanisms. The Three R’s – Replacement (use non‑animal alternatives when possible), Reduction (use the fewest animals needed), Refinement (minimize pain and distress). Model validation – an animal model must recapitulate key clinical features (pathology, biomarkers, therapeutic response) of the human disease. --- 📌 Must Remember Genetic similarity: Human–chimp ≈ 99 %; human–rodent > 90 %; < 1 % of mouse genes differ from humans. Traits prized in models: short life cycle, easy genetic manipulation, simple husbandry. Key model organisms: E. coli, S. cerevisiae, S. pombe, D. melanogaster, C. elegans, mouse, rat, zebrafish, non‑human primates. Common limitations: species‑specific physiology (e.g., mice lack IL‑8), genetic homogeneity vs human diversity, microbiome‑driven bias. Ethical rule‑of‑thumb: Always justify necessity for human benefit, minimize suffering, and apply humane euthanasia. --- 🔄 Key Processes Choosing a Model Organism Define disease question → list required biological features → assess phylogenetic closeness & experimental tractability → weigh cost, ethics, and existing knowledge. Validating an Animal Model Compare animal phenotype to human disease (clinical signs, biomarkers). Verify that the same molecular pathways are engaged. Test response to standard human therapies. Designing an Animal Study Select species/strain → calculate sample size (power analysis) → randomize & blind → include appropriate controls (sham, vehicle, negative) → apply refinement measures. --- 🔍 Key Comparisons Homologous vs Isomorphic vs Predictive Cause: Same (homologous) ⟶ Different (isomorphic) ⟶ Partial/irrelevant (predictive) Symptoms: Same (homologous & isomorphic) ⟶ Limited (predictive) Treatment: Same (homologous & isomorphic) ⟶ May differ (predictive) Mouse vs Rat Size: Mouse – tiny, high‑throughput; Rat – larger organs, better for surgery & physiology. Genetic tools: Mouse – extensive knock‑out/CRISPR libraries; Rat – fewer but growing. Invertebrate vs Vertebrate models Genetic tractability: Invertebrates (fly, worm) → very high; Vertebrates → moderate to high (mouse). Physiological relevance: Vertebrates → closer to humans (immune, organ systems); Invertebrates → limited for systemic studies. --- ⚠️ Common Misunderstandings “Mice are identical to humans.” – They share > 90 % of genes, but lack key immune components (e.g., IL‑8) and often have sedentary, obese phenotypes that skew metabolic studies. “If a gene is conserved, the phenotype will be the same.” – Gene context, regulatory networks, and species‑specific modifiers can alter outcomes. “All animal models are predictive for drug efficacy.” – Species differences in ADME (absorption, distribution, metabolism, excretion) frequently cause poor translation to humans. --- 🧠 Mental Models / Intuition Phylogenetic proximity ≈ functional similarity – Think of a family tree: the closer the branch, the more likely shared “traits” (genes, pathways). Model “layers” – Visualize disease modeling as layers: genetic → cellular → organ → organism. Choose the simplest layer that still captures the research question. Three R’s as a decision filter: Before any experiment, ask “Can I Replace? Reduce? Refine?” → if “yes” to any, adjust the plan. --- 🚩 Exceptions & Edge Cases Non‑human primates – Offer the highest translational fidelity for cognition, HIV, and vaccine work, but ethical restrictions often preclude routine use. Orphan models – Some diseases exist only in the animal species (e.g., certain rodent‑specific tumors); these are valuable for basic biology but have limited human relevance. Spontaneous vs Experimental models – Spontaneous models may better mimic disease onset but are less controllable; experimental models allow precise timing and dosage. --- 📍 When to Use Which Genetic studies → Drosophila, C. elegans, yeast, mouse (in‑bred strains, CRISPR). Developmental biology → zebrafish (transparent embryos) or Xenopus (large embryos). Immunology & vaccine testing → non‑human primates (closest immune system) or mouse (with humanized immune components). Metabolic/obesity research → high‑fat‑diet mouse or rat models; beware of sedentary bias. Neurobehavioral assays → Drosophila (simple circuits), mouse (complex cognition). Drug ADME studies → mouse or rat for whole‑organism pharmacokinetics; supplement with in‑vitro hepatocyte assays for human‑specific metabolism. --- 👀 Patterns to Recognize Conserved pathway → conserved phenotype – When a pathway is highly conserved across species, phenotypic effects of its manipulation often translate. Phenocopy vs true disease – If the animal shows only superficial symptoms without underlying pathology, it’s likely a phenocopy (predictive model). Microbiome influence – Changes in gut flora often co‑occur with metabolic or immune phenotypes; look for microbiome‑related variables in study design. --- 🗂️ Exam Traps “All mouse models are genetically identical.” – Only inbred strains are uniform; outbred stocks exist and are used for heterogeneity studies. “Higher phylogenetic similarity always means better translational value.” – Practical tractability and ethical constraints can outweigh closeness (e.g., chimpanzees vs mouse). “Replacement means no animal work at all.” – Replacement can involve using lower‑order organisms (e.g., C. elegans) rather than eliminating animals entirely. “If a disease is homologous in an animal, the drug response will be identical.” – Species‑specific pharmacodynamics/pharmacokinetics often differ; efficacy must still be verified. ---